Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NUMORPHAN SUPPOSITORY 5MG DIN 01916513

Status: Cancelled Post Market
Holder: BRISTOL-MYERS SQUIBB CANADA
Molecule: OXYMORPHONE HYDROCHLORIDE

Health Canada record

Active ingredient(s)OXYMORPHONE HYDROCHLORIDE 5 MG
Dosage formSuppository
RouteRectal
ScheduleNARCOTICS (CDSA I)
ClassHuman
ATCN02AA NATURAL OPIUM ALKALOIDS
Original market date31-Dec-1993
Current status date04-Jul-2002
SourceHealth Canada DPD

Establishment licence of the holder

Bristol-Myers Squibb Canada — licence 100100, currently licensed, last inspection rating C (2026-03-18).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing OXYMORPHONE HYDROCHLORIDE

DINProductCompanyFormStrengthStatus
01916505NUMORPHAN INJECTION 1.5MG/MLBRISTOL-MYERS SQUIBB CANADALiquidOXYMORPHONE HYDROCHLORIDE 1.5 MGCancelled Post Market
02383403OPANA ERPALADIN PHARMA INC.Tablet (Extended-Release)OXYMORPHONE HYDROCHLORIDE 5 MGCancelled Pre Market
02383438OPANA ERPALADIN PHARMA INC.Tablet (Extended-Release)OXYMORPHONE HYDROCHLORIDE 10 MGCancelled Pre Market
02383454OPANA ERPALADIN PHARMA INC.Tablet (Extended-Release)OXYMORPHONE HYDROCHLORIDE 20 MGCancelled Pre Market
02383470OPANA ERPALADIN PHARMA INC.Tablet (Extended-Release)OXYMORPHONE HYDROCHLORIDE 40 MGCancelled Pre Market

International API supply for OXYMORPHONE HYDROCHLORIDE

2 active FDA Drug Master Files.

Request a quote for NUMORPHAN SUPPOSITORY 5MG

How to read a Canadian DIN record